clomipramine has been researched along with Movement Disorders in 3 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open, nonblind clinical trial, clomipramine reduced adventitious movements and compulsions in five previously medicated prepubertal boys with autistic disorder and severe mental retardation." | 9.07 | Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. ( Aisemberg, P; Barnett, JY; Brasic, JR; Clark, A; Kaplan, D; Kowalik, S; Lafargue, RT; Sheitman, BB; Tsaltas, MO; Young, JG, 1994) |
| "In an open, nonblind clinical trial, clomipramine reduced adventitious movements and compulsions in five previously medicated prepubertal boys with autistic disorder and severe mental retardation." | 5.07 | Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation. ( Aisemberg, P; Barnett, JY; Brasic, JR; Clark, A; Kaplan, D; Kowalik, S; Lafargue, RT; Sheitman, BB; Tsaltas, MO; Young, JG, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brasic, JR | 2 |
| Barnett, JY | 2 |
| Kaplan, D | 1 |
| Sheitman, BB | 2 |
| Aisemberg, P | 1 |
| Lafargue, RT | 1 |
| Kowalik, S | 1 |
| Clark, A | 1 |
| Tsaltas, MO | 2 |
| Young, JG | 1 |
| Lewis, MH | 1 |
| Bodfish, JW | 1 |
| Powell, SB | 1 |
| Golden, RN | 1 |
3 trials available for clomipramine and Movement Disorders
| Article | Year |
|---|---|
Clomipramine ameliorates adventitious movements and compulsions in prepubertal boys with autistic disorder and severe mental retardation.
Topics: Autistic Disorder; Child; Clomipramine; Humans; Intellectual Disability; Male; Movement Disorders; P | 1994 |
Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation.
Topics: Adolescent; Adult; Clomipramine; Cross-Over Studies; Double-Blind Method; Female; Humans; Intellectu | 1995 |
Adverse effects of clomipramine.
Topics: Aggression; Akathisia, Drug-Induced; Autistic Disorder; Child; Clomipramine; Compulsive Behavior; Hu | 1997 |